Day: May 25, 2021
Focus on recapitalization, pipeline growth, and optimization of run stage in Oregon
PORTLAND, Ore., May 25, 2021 (GLOBE NEWSWIRE) — Chalice Brands Ltd., formerly Golden Leaf Holdings Ltd. (CSE:CHAL) (OTCQB:GLDFF) (“Chalice” or the “Company”), a premier consumer-driven cannabis company specializing in retail, production, processing, wholesale, and distribution, today announces its financial and operating results for the first quarter 2021. All amounts stated are in US Dollars unless otherwise noted.
Q1 2021 Financial Highlights:Record quarterly revenues from continuing operations of $5.5 million, a 18% year-over-year increase compared to $4.7 million for the same period in 2020.
Gross profit for Q1 2021 of $2.5M or 45% gross margin compared to $1.7M or 37% gross margin in 2020. Gross margin improvements are due to increased sales...
Arbor Realty Trust, Inc. Announces Public Offering of Series D Cumulative Redeemable Preferred Stock
Written by Customer Service on . Posted in Public Companies.
UNIONDALE, N.Y., May 25, 2021 (GLOBE NEWSWIRE) — Arbor Realty Trust, Inc. (the “Company”) (NYSE: ABR) announced today that it plans to make a public offering of an initial issuance of its Series D Cumulative Redeemable Preferred Stock (the “Series D Preferred Stock”). In connection with the offering, the Company intends to grant the underwriters a 30-day option to purchase additional shares of Series D Preferred Stock to cover over-allotments, if any. The Company intends to file an application to list the Series D Preferred Stock on the NYSE under the symbol “ABR PrD” and, if approved, expects trading to commence within 30 days after the initial issuance of the Series D Preferred Stock.The Company intends to use the net proceeds from the offering to make investments relating to its business and for general corporate purposes,...
Resonant to Host One-On-One Meetings at the 18th Annual Craig-Hallum Institutional Investor Conference on June 2nd
Written by Customer Service on . Posted in Public Companies.
AUSTIN, Texas, May 25, 2021 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), a provider of radio frequency (RF) filter solutions developed on a robust intellectual property platform, designed to connect People and Things, today announced that management will participate in the 18th Annual Craig-Hallum Institutional Investor Conference taking place on Wednesday, June 2, 2021.
Resonant management will provide a business update and RF filter industry overview, focusing on how Resonant’s XBAR® RF filter technology is facilitating the transition to next-generation, ultra-fast wireless networks like 5G, Wi-Fi 6E, and Ultra-wideband.
Resonant management will host virtual one-on-one meetings throughout the day on Wednesday, June 2nd. Conference participation is by invitation only and registration is mandatory. To schedule a one-on-one...
ME2C® Environmental Announces Court Approval to Proceed with Litigation Claims Against Refined Coal Entities
Written by Customer Service on . Posted in Public Companies.
Response from the U.S District Court in Delaware Allows Litigation Proceedings to Move Forward
CORSICANA, TX, May 25, 2021 (GLOBE NEWSWIRE) — Midwest Energy Emissions Corp. (OTCQB: MEEC) (“ME2C Environmental” or the “Company”), a leading environmental technologies firm, announced today that on May 20, 2021, a U.S. District Court Magistrate Judge for the District of Delaware issued a Report and Recommendation that the pending patent litigation commenced in 2019 should be allowed to move forward against 16 key refined coal process defendants named in such lawsuit.
“We are extremely pleased with the Court’s recommendation against those entities whom we believe have been infringing on our patented mercury capture technologies since the inception of the refined coal program,” said Richard MacPherson, CEO of ME2C Environmental....
Hamilton Thorne Reports Financial and Operational Results for the Quarter-Ended March 31, 2021
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Revenues up 11% to $11.5 million; Adjusted EBITDA up 27% to $2.3 million
BEVERLY, Mass. and TORONTO, May 25, 2021 (GLOBE NEWSWIRE) — Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported financial and operational results for the quarter-ended March 31, 2021.
HighlightsSales in USD increased 11% year over year to $11.5 million; organic growth up 11%
Gross profit increased 13% year over year to $5.9 million
Net income increased 495% to $866 thousand
Adjusted EBITDA increased 27% year over year to $2.3 million
Sales increased 5% in constant currency; organic constant currency growth up 5%
Cash flow from operations was $1.5 million for the quarter, up 111%; total cash at March...
Golden Star Enterprises Ltd. Announces Acquisition and Introduces New Corporate Mandate
Written by Customer Service on . Posted in Mergers And Acquisitions.
Claymont, DE, May 25, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Golden Star Enterprises Ltd. (OTCPink: GSPT) reports it has recently completed a change in management and has shifted its operational focus going forward.
Previously, the cornerstone of the operations of Golden Star Enterprises was drone technology. The current management of GSPT has determined to change its corporate direction, ceasing operations in the drone space and introducing a new corporate mandate.
“Our goal for GSPT is to provide an accelerator hub for cutting-edge tech companies,” said Mr. Eliav Kling, Golden Star Enterprises CEO. “We would like to be able to serve as a holding company for a series of operating entities with complementary business models, all under the Golden Star Enterprises umbrella.”
To further the Company’s new corporate focus,...
Rain Therapeutics Reports First Quarter 2021 Financial Results and Highlights Recent Progress
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Completed initial public offering (“IPO”) with net proceeds of $121.9 million
Key appointments to the leadership team, board of directors and scientific advisory board
Planned Phase 3 trial initiation in 2H 2021 for RAIN-32 in well-differentiated (“WD”)/de-differentiated (“DD”) liposarcoma
Planned initiation of an open-label MDM2-amplified tumor-agnostic Phase 2 basket trial for RAIN-32 in 2H 2021
NEWARK, Calif., May 25, 2021 (GLOBE NEWSWIRE) — Rain Therapeutics Inc. (“Rain”), a clinical-stage company developing precision oncology therapeutics, today reports financial results for the first quarter that ended March 31, 2021, along with an update on the company’s key developments, business operations and upcoming milestones.
“We are thrilled with the progress made so far this year, which...
Nokia launches world’s first AI use case library on public cloud for telecoms providers
Written by Customer Service on . Posted in Public Companies.
Press Release
Nokia launches world’s first AI use case library on public cloud for telecoms providersNokia’s AVA AI use case library is now delivered as a service on Microsoft Azure’s public cloud, combining telco grade security and instant web scale architecture scalability.
Accelerates communication service providers (CSPs) digital transformation, increases efficiency, reduces energy consumption and improves customer experience.
CSPs around the world can now inject AI into their networks nine times faster compared to using private cloud.25th of May 2021
Espoo, Finland – Nokia today announced the world’s first deployment of multiple AI use cases delivered over public cloud, through collaboration with Microsoft. By integrating Nokia’s security framework with Microsoft Azure’s digital architecture, communications service providers...
PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig’s Disease
Written by Customer Service on . Posted in Public Companies.
TORONTO, May 25, 2021 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company, is pleased to announce that it has filed an application with the U.S. Food and Drug Administration (“FDA”) to receive Orphan Drug Designation (“ODD”) for ketamine to treat amyotrophic lateral sclerosis (“ALS”), also known as Lou Gehrig’s disease.
ALS is a progressive neuromuscular disease with a life expectancy of only two to six years after diagnosis. Currently, there is no known cure for ALS. ALS affects approximately 50,000 people in the U.S. and Europe, with over 5,000 new cases diagnosed annually. As ALS advances, upper and lower motor neurons die, causing the brain to lose its ability to control muscle movement. ALS patients experience progressive...
Motus GI’s Pure-Vu System® Adopted by Sinai Hospital of Baltimore
Written by Customer Service on . Posted in Public Companies.
Implementation of the Pure-Vu System is designed to improve efficiencies and outcomes of GI endoscopy procedures
FORT LAUDERDALE, Fla., May 25, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company providing endoscopy solutions that improve clinical outcomes and enhance the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions, announced today that Sinai Hospital of Baltimore, a LifeBridge Health center, will move ahead with fully adopting the Pure-Vu® System with the aim of improving efficiencies and clinical outcomes of inpatient colonoscopy procedures for patients who present with inadequate bowel preparation. Sinai Hospital, a nonprofit teaching hospital with renowned Centers of Excellence, is...